share_log

华昊中天医药-B(02563)以下限定价 公开发售获21.45倍认购

Huahao Zhongtian Pharmaceutical-B (02563) is priced at a maximum of 21.45 times the public offering subscription.

Zhitong Finance ·  Oct 30, 2024 07:31

Huahao Zhongtian Pharmaceutical-B (02563) announced the allotment results. The company plans to sell 14.588 million shares globally, public...

According to the Zhitong Finance App, Huahao Zhongtian Pharmaceutical-B (02563) announced the allotment results. The company plans to sell 14.588 million shares globally, accounting for 12% of the public sale and 88% for the international sale. The final sale price was HK$16 per share, with a net raise of approximately HK$0.196 billion from the global sale. Each lot is 200 shares. It is expected that trading of shares on the Stock Exchange will begin at 9:00 a.m. (Hong Kong time) on October 31, 2024 (Thursday).

Among them, the public sale received 21.45 times the subscription, and the international sale received 0.994 times the subscription.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment